OTC Markets OTCPK - Delayed Quote USD

Hamilton Thorne Ltd. (HTLZF)

Compare
1.5880 0.0000 (0.00%)
At close: September 17 at 4:00 PM EDT
Loading Chart for HTLZF
DELL
  • Previous Close 0.0000
  • Open 1.5800
  • Bid 1.5800 x 40000
  • Ask 1.5900 x 40000
  • Day's Range 1.5800 - 1.5800
  • 52 Week Range 0.8030 - 1.5900
  • Volume 1,000
  • Avg. Volume 28,920
  • Market Cap (intraday) 244.396M
  • Beta (5Y Monthly) 0.42
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date Nov 11, 2024 - Nov 15, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, laboratory equipment, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. The company offers precision laser systems and imaging systems for biology markets. It also provides test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services. In addition, the company manufactures and distributes medical products for reproductive medicine; manufactures bespoke workstations, incubators, and equipment for IVF laboratories; researches, designs, develops, sells, installs, and services in-vitro diagnostic systems; and manufactures ovum pickup needles, catheters, and other devices. Further, the company offers Cell-Tek Microscope Chamber, a product for controlling temperature, air flow, humidification, and air quality; laminar flow workstations, incubators, and related products; and artificial intelligence enabled CASA software, consumables, and image analysis systems for the ART and laboratory markets, as well as capital equipment and consumables, software, and other services. It sells its products and services under Hamilton Thorne, Gynemed, Planer, Tek-Event, IVFtech, MICROPTIC, Gynétics, and Embryotech brand names through a direct sales force in the United States, Germany, France, Australia, Denmark, Belgium, Spain, and the United Kingdom, as well as through distributors to fertility clinics, hospitals, pharmaceutical companies, biotechnology companies, educational institutions, and other commercial and academic research establishments in approximately 100 countries. Hamilton Thorne Ltd. is headquartered in Beverly, Massachusetts.

www.hamiltonthorne.ltd

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: HTLZF

View More

Performance Overview: HTLZF

Trailing total returns as of 9/17/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

HTLZF
57.23%
S&P/TSX Composite index
12.97%

1-Year Return

HTLZF
58.80%
S&P/TSX Composite index
14.82%

3-Year Return

HTLZF
1.34%
S&P/TSX Composite index
14.93%

5-Year Return

HTLZF
103.33%
S&P/TSX Composite index
41.35%

Compare To: HTLZF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: HTLZF

View More

Valuation Measures

Annual
As of 9/17/2024
  • Market Cap

    242.39M

  • Enterprise Value

    259.43M

  • Trailing P/E

    --

  • Forward P/E

    45.45

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.31

  • Price/Book (mrq)

    3.87

  • Enterprise Value/Revenue

    3.57

  • Enterprise Value/EBITDA

    41.83

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -2.34%

  • Return on Assets (ttm)

    0.31%

  • Return on Equity (ttm)

    -2.79%

  • Revenue (ttm)

    72.57M

  • Net Income Avi to Common (ttm)

    -1.7M

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    8.99M

  • Total Debt/Equity (mrq)

    41.23%

  • Levered Free Cash Flow (ttm)

    2.9M

Research Analysis: HTLZF

View More

Earnings Per Share

Consensus EPS
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Company Insights: HTLZF

People Also Watch